Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ

$5.22

$-0.10

(-1.88%)

Pre-Market

Atea Pharmaceuticals, Inc. (AVIR) Live Price Chart

Last updated: ⁦2026-09-16 10:32:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Atea Pharmaceuticals, Inc. (AVIR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.22, with a market capitalisation of $426.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.78 to $6.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$426.69M
Open	$5.30
Day's High	$94.17
Day's Low	$2.46
Previous Close	$5.32
Volume	184.05K
Average Volume	329.32K
P/E Ratio	--
52-Week High	$6.45
52-Week Low	$2.78
Dividend Yield	--
Earnings Date	--

Atea Pharmaceuticals, Inc. (AVIR) Pre-Market Stock Price

Atea Pharmaceuticals, Inc. (AVIR) is trading at $5.26 in pre-market trading as of 2026-09-15 23:31:00, down 1.22% ($0.07) from the previous close of $5.32

Pre-market trading shows how investors are pricing AVIR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Atea Pharmaceuticals, Inc. (AVIR) 7-Day Stock Price Change

Over the past seven days, Atea Pharmaceuticals, Inc. (AVIR) moved from $5.83 to $5.22, representing a decline of 10.45% ($0.61).

The stock traded between $5.12 and $5.90 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 298.48 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

AVIR 52-Week Price Position

Position in Range: 66.5%

52W Low$2.78

52W High$6.45

AVIR is currently trading at $5.22, placing it 66.5% of the way from its 52-week low of $2.78 to its 52-week high of $6.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Atea Pharmaceuticals, Inc. (AVIR)?

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Atea Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	55
Exchange	NASDAQ
Company Website	https://www.ateapharma.com

How to Buy Atea Pharmaceuticals, Inc. (AVIR) Stock on MEXC

Eligible investors can buy real shares of Atea Pharmaceuticals, Inc. (AVIR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVIR and Place Your Order

Open the RealStocks trading page and search for AVIR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Atea Pharmaceuticals, Inc. (AVIR) stock price today?

Atea Pharmaceuticals, Inc. (AVIR) is currently trading at $ 5.22, down 1.86% ($0.10) from the previous close of $ 5.32. Intraday prices update in real time during regular trading hours.

2.Is AVIR stock going up or down today?

As of 2026-09-15 23:31:00, AVIR is trading at $ 5.22, down 1.86% ($0.10) from its previous close of $ 5.32. The stock has traded between $ 2.46 and $ 94.17 during today’s regular session. Past price movements do not guarantee future results.

3.What is AVIR pre-market price?

As of 2026-09-15 23:31:00, AVIR is trading at $ 5.26 in pre-market trading, down 1.22% ($0.07) from the previous close of $ 5.32. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVIR after-hours price?

As of 2026-09-15 23:31:00, AVIR is trading at $ 5.23 in after-hours trading, down 1.69% ($0.09) from the regular-session close of $ 5.32. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVIR stock trading now?

AVIR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVIR sit relative to its 52-week high and low?

Over the past 52 weeks, AVIR has traded between a low of $ 2.78 and a high of $ 6.45. At $ 5.22, the stock is positioned 66.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Atea Pharmaceuticals, Inc. in?

Atea Pharmaceuticals, Inc. (AVIR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Atea Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Atea Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 426.69M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVIR valued in terms of P/E ratio and EPS?

AVIR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.06. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Atea Pharmaceuticals, Inc. pay a dividend?

Atea Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.